PortfoliosLab logo
SEEL vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SEEL and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

SEEL vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Seelos Therapeutics, Inc. (SEEL) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

SEEL:

$214.97K

PFE:

$133.55B

EPS

SEEL:

$351.04

PFE:

$1.38

PE Ratio

SEEL:

0.00

PFE:

17.02

PS Ratio

SEEL:

0.11

PFE:

2.14

PB Ratio

SEEL:

15.10

PFE:

1.48

Total Revenue (TTM)

SEEL:

$376.00K

PFE:

$62.46B

Gross Profit (TTM)

SEEL:

$361.00K

PFE:

$42.09B

EBITDA (TTM)

SEEL:

-$3.12M

PFE:

$17.24B

Returns By Period


SEEL

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

PFE

YTD

-8.28%

1M

0.03%

6M

-7.16%

1Y

-12.56%

3Y*

-19.73%

5Y*

-4.00%

10Y*

0.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Seelos Therapeutics, Inc.

Pfizer Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

SEEL vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SEEL
The Risk-Adjusted Performance Rank of SEEL is 88
Overall Rank
The Sharpe Ratio Rank of SEEL is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of SEEL is 00
Sortino Ratio Rank
The Omega Ratio Rank of SEEL is 11
Omega Ratio Rank
The Calmar Ratio Rank of SEEL is 00
Calmar Ratio Rank
The Martin Ratio Rank of SEEL is 2020
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2828
Overall Rank
The Sharpe Ratio Rank of PFE is 2424
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2222
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2323
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3838
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 3333
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SEEL vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Seelos Therapeutics, Inc. (SEEL) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

SEEL vs. PFE - Dividend Comparison

SEEL has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.24%.


TTM20242023202220212020201920182017201620152014
SEEL
Seelos Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
7.24%6.33%5.70%3.12%2.64%3.91%3.67%3.11%3.53%3.69%3.46%3.33%

Drawdowns

SEEL vs. PFE - Drawdown Comparison


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

SEEL vs. PFE - Volatility Comparison


Loading data...

Financials

SEEL vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Seelos Therapeutics, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20212022202320242025
376.00K
13.72B
(SEEL) Total Revenue
(PFE) Total Revenue
Values in USD except per share items